Bingyi Shi
Research Subjects
Research Interests
Bingyi Shi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Haiyan Huang
Beijing Key Laboratory of Organ Transplant and Immune Regulation, Transplant Research Laboratory of Organ Transplantation Institute, The 309th Hospital of Chinese People's Liberation Army, Beijing 100091, P.R. China
2 shared publications- Li Xiao
College of Pulmonary and Critical Care Medicine, Beijing Key Laboratory of Organ Transplantation and Immunology Regulatory, The 8th Medical Centre of Chinese PLA General Hospital, Beijing, China
2 shared publications Lili Bi
Beijing Key Laboratory of Immunology Regulatory and Organ Transplantation, Basic Research Lab of Organ Transplant Institute, The Eighth Medical Center of Chinese PLA General Hospital, Beijing 100091, China
2 shared publicationsXiaoguang Xu
Beijing Key Laboratory of Organ Transplant and Immune Regulation, Transplant Research Laboratory of Organ Transplantation Institute, The 309th Hospital of Chinese People's Liberation Army, Beijing 100091, P.R. China
2 shared publicationsYeyong Qian
Beijing Key Laboratory of Immunology Regulatory and Organ Transplantation, Basic Research Lab of Organ Transplant Institute, The Eighth Medical Center of Chinese PLA General Hospital, Beijing 100091, China
2 shared publicationsB. Sun
Organ Transplantation Institute, Beijing Key Laboratory of Organ Transplantation and Immune Regulation, 309th Hospital of the Chinese People's Liberation Army, Beijing, China
1 shared publication
Latest Publications
- 24 February 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (2) , 364-367
Global Perspective on Kidney Transplantation: China
Chronic renal failure, progressing to the irreversible condition of ESKD, requires efficient RRT, typically dialysis or kidney transplantation (1). Compared with dialysis, kidney transplantation significantly benefits the survival and quality of life of ESKD patients and carries less of a burden. This minireview summarizes the development of kidney transplantation in China in recent years. In addition, we briefly introduce the human organ sharing system in China, which helps achieve justifiable, fair, and transparent organ allocation.
- 24 February 2022
- Published by Wolters Kluwer Health in Kidney360
- Vol. 3 (2) , 364-367
Global Perspective on Kidney Transplantation: China
Chronic renal failure, progressing to the irreversible condition of ESKD, requires efficient RRT, typically dialysis or kidney transplantation (1). Compared with dialysis, kidney transplantation significantly benefits the survival and quality of life of ESKD patients and carries less of a burden. This minireview summarizes the development of kidney transplantation in China in recent years. In addition, we briefly introduce the human organ sharing system in China, which helps achieve justifiable, fair, and transparent organ allocation.
- Open Access
- 18 March 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 133 (7) , 760-765
Development of the organ donation and transplantation system in China
- 18 March 2020
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 133 (7) , 760-765
Open AccessDevelopment of the organ donation and transplantation system in China
- 1 February 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 869, 172872
The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients
- 1 February 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 869, 172872
The advantage of Sirolimus in amplifying regulatory B cells and regulatory T cells in liver transplant patients
- Open Access
- 15 May 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-9
Follicular Helper T Cell Derived Exosomes Promote B Cell Proliferation and Differentiation in Antibody-Mediated Rejection after Renal Transplantation
Follicular helper T cells (Tfh cells) are closely related to the occurrence and development of antibody-mediated rejection (AMR) after renal transplantation. Exosomes play a key role in the rejection after organ transplantation. However, whether Tfh-derived exosomes are involved in AMR has not been reported. We collected peripheral blood from 42 kidney transplant patients and found no significant differences in CD4+CXCR5+ and CD4+CXCR5+CXCR3+CCR6-exosomes between AMR and non-AMR groups, whereas the proportion of CD4+CXCR5+CXCR3-exosomes was significantly higher in AMR group than that in non-AMR group; CTLA-4 expression of CD4+CXCR5+exosomes was significantly lower in AMR group than that in non-AMR group. HLA-G expression was not significantly different between two groups. We further separated CD4+CXCR5+cells from patients by magnetic beads. Coculture experiments showed that Tfh cell-derived exosomes in AMR patients significantly promoted B cell proliferation and differentiation, compared with non-AMR group, the percentage of B cells and plasma cells increased by 87.52% and 110.2%, respectively. In conclusion, our study found that Tfh cell-derived exosomes could promote the proliferation and differentiation of B cells and they may play an important role in the development of AMR after renal transplantation.
- 15 May 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-9
Open AccessFollicular Helper T Cell Derived Exosomes Promote B Cell Proliferation and Differentiation in Antibody-Mediated Rejection after Renal Transplantation
Follicular helper T cells (Tfh cells) are closely related to the occurrence and development of antibody-mediated rejection (AMR) after renal transplantation. Exosomes play a key role in the rejection after organ transplantation. However, whether Tfh-derived exosomes are involved in AMR has not been reported. We collected peripheral blood from 42 kidney transplant patients and found no significant differences in CD4+CXCR5+ and CD4+CXCR5+CXCR3+CCR6-exosomes between AMR and non-AMR groups, whereas the proportion of CD4+CXCR5+CXCR3-exosomes was significantly higher in AMR group than that in non-AMR group; CTLA-4 expression of CD4+CXCR5+exosomes was significantly lower in AMR group than that in non-AMR group. HLA-G expression was not significantly different between two groups. We further separated CD4+CXCR5+cells from patients by magnetic beads. Coculture experiments showed that Tfh cell-derived exosomes in AMR patients significantly promoted B cell proliferation and differentiation, compared with non-AMR group, the percentage of B cells and plasma cells increased by 87.52% and 110.2%, respectively. In conclusion, our study found that Tfh cell-derived exosomes could promote the proliferation and differentiation of B cells and they may play an important role in the development of AMR after renal transplantation.
- Open Access
- 27 March 2019
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (5) , 4238-4248
Circulating NK cell subsets and NKT‑like cells in renal transplant recipients with acute T‑cell‑mediated renal allograft rejection
Emerging evidence indicates that natural killer (NK) cells and NKT‑like cells may affect allograft outcomes following solid organ transplantation. However, the roles of these cells in allograft acceptance and dysfunction are controversial. To assess the changes in NK cell and CD3+CD56+ NKT‑like cell frequency and phenotype in renal allograft recipients and to explore their associations with acute T‑cell‑mediated renal allograft rejection (ACR), longitudinal changes in NK and NKT‑like cell frequency and phenotype were characterized using flow cytometry and immunohistochemistry in the peripheral blood and kidney allograft tissues in 142 recipients undergoing kidney transplantation. The serum concentrations of NK cell‑associated cytokines were also detected by cytokine multiplex immunoassay. In contrast to the healthy controls, recipients with stable graft function exhibited increased proportions of CD56brightCD16dim subsets and decreased proportions of NKT‑like cells in their peripheral blood mononuclear cells (PBMCs). Patients with ACR demonstrated increased proportions of NK cells, which were associated with increased CD3‑CD56bright subsets and decreased CD3‑CD56dim subsets, an increase in the CD56bright/CD56dim ratio in PBMCs and increased CD56+ NK cell infiltration in the kidney allograft, compared with the stable controls. In addition, there was a decreased proportion of NKT‑like cells in patients with ACR, and an increased ratio of CD56bright/NKT‑like cells compared with the stable controls. These differences appeared to be consistent with the increase in the serum concentrations of C‑C motif chemokine 19 and the decrease in the serum concentrations of interleukin‑15. These data indicate that CD56bright NK cells may promote the development of ACR, and that NKT‑like cells may have immunoregulatory function. The results also imply that the CD56bright/CD56dim ratio may affect the ACR signatures.
- 27 March 2019
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 19 (5) , 4238-4248
Open AccessCirculating NK cell subsets and NKT‑like cells in renal transplant recipients with acute T‑cell‑mediated renal allograft rejection
Emerging evidence indicates that natural killer (NK) cells and NKT‑like cells may affect allograft outcomes following solid organ transplantation. However, the roles of these cells in allograft acceptance and dysfunction are controversial. To assess the changes in NK cell and CD3+CD56+ NKT‑like cell frequency and phenotype in renal allograft recipients and to explore their associations with acute T‑cell‑mediated renal allograft rejection (ACR), longitudinal changes in NK and NKT‑like cell frequency and phenotype were characterized using flow cytometry and immunohistochemistry in the peripheral blood and kidney allograft tissues in 142 recipients undergoing kidney transplantation. The serum concentrations of NK cell‑associated cytokines were also detected by cytokine multiplex immunoassay. In contrast to the healthy controls, recipients with stable graft function exhibited increased proportions of CD56brightCD16dim subsets and decreased proportions of NKT‑like cells in their peripheral blood mononuclear cells (PBMCs). Patients with ACR demonstrated increased proportions of NK cells, which were associated with increased CD3‑CD56bright subsets and decreased CD3‑CD56dim subsets, an increase in the CD56bright/CD56dim ratio in PBMCs and increased CD56+ NK cell infiltration in the kidney allograft, compared with the stable controls. In addition, there was a decreased proportion of NKT‑like cells in patients with ACR, and an increased ratio of CD56bright/NKT‑like cells compared with the stable controls. These differences appeared to be consistent with the increase in the serum concentrations of C‑C motif chemokine 19 and the decrease in the serum concentrations of interleukin‑15. These data indicate that CD56bright NK cells may promote the development of ACR, and that NKT‑like cells may have immunoregulatory function. The results also imply that the CD56bright/CD56dim ratio may affect the ACR signatures.
- 1 December 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (10) , 3906-3910
Infusion of Lymphocytes Treated With 8-Methoxypsoralen and Ultraviolet A Light Induces CD19+IL-10+ Regulatory B Cells and Promotes Skin Allograft Survival
- 1 December 2018
- Published by Elsevier in Transplantation Proceedings
- Vol. 50 (10) , 3906-3910
Infusion of Lymphocytes Treated With 8-Methoxypsoralen and Ultraviolet A Light Induces CD19+IL-10+ Regulatory B Cells and Promotes Skin Allograft Survival
- Open Access
- 23 October 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 9 (1) , 45-50
Serum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation
The early diagnosis of acute rejection is crucial for graft survival after kidney transplantation. The interferon-γ (IFNγ)-CXCR3-chemokine-dependent inflammatory loop plays a pivotal role in the recruitment of T lymphocytes during acute rejection. Previously published studies have typically focused on the CXCR3 receptor rather than on its ligands. In the present study, we used Luminex assays to detect the levels of CXCR3 ligands, monokine induced by IFNγ (MIG), IFN-induced protein 10 (IP-10) and IFN-induced T‑cell chemoattractant (I-TAC), in the serum of renal allograft recipients. According to a renal biopsy performed one month after kidney transplantation, 32 recipients were diagnosed with T cell-mediated acute rejection and 38 patients were evaluated as stable. Serum was collected after the diagnosis of acute rejection or one month after transplantation. The concentrations of MIG (median, 4,271 pg/ml), IP-10 (median, 686.7 pg/ml) and I-TAC (median, 44.32 pg/ml) in the serum during an acute rejection episode were significantly higher compared with those of the stable patients (MIG, P=0.0002; IP-10, P=0.0001; I-TAC, P=0.0103; vs. the stable function group, P<0.05). Based on the receiver-operating characteristic (ROC) curve, the joint detection of MIG, IP-10 and I-TAC in the serum using Luminex analysis may constitute a non-invasive and efficient method for the early prediction of T cell-mediated acute rejection following kidney transplantation.
- 23 October 2013
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 9 (1) , 45-50
Open AccessSerum levels of CXCR3 ligands predict T cell-mediated acute rejection after kidney transplantation
The early diagnosis of acute rejection is crucial for graft survival after kidney transplantation. The interferon-γ (IFNγ)-CXCR3-chemokine-dependent inflammatory loop plays a pivotal role in the recruitment of T lymphocytes during acute rejection. Previously published studies have typically focused on the CXCR3 receptor rather than on its ligands. In the present study, we used Luminex assays to detect the levels of CXCR3 ligands, monokine induced by IFNγ (MIG), IFN-induced protein 10 (IP-10) and IFN-induced T‑cell chemoattractant (I-TAC), in the serum of renal allograft recipients. According to a renal biopsy performed one month after kidney transplantation, 32 recipients were diagnosed with T cell-mediated acute rejection and 38 patients were evaluated as stable. Serum was collected after the diagnosis of acute rejection or one month after transplantation. The concentrations of MIG (median, 4,271 pg/ml), IP-10 (median, 686.7 pg/ml) and I-TAC (median, 44.32 pg/ml) in the serum during an acute rejection episode were significantly higher compared with those of the stable patients (MIG, P=0.0002; IP-10, P=0.0001; I-TAC, P=0.0103; vs. the stable function group, P<0.05). Based on the receiver-operating characteristic (ROC) curve, the joint detection of MIG, IP-10 and I-TAC in the serum using Luminex analysis may constitute a non-invasive and efficient method for the early prediction of T cell-mediated acute rejection following kidney transplantation.